<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35121209</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5883</ISSN><JournalIssue CitedMedium="Internet"><Volume>434</Volume><PubDate><Year>2022</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the neurological sciences</Title><ISOAbbreviation>J Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.</ArticleTitle><Pagination><StartPage>120162</StartPage><MedlinePgn>120162</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jns.2022.120162</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-510X(22)00021-1</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Neurological and neuropsychiatric symptoms that persist or develop three months after the onset of COVID-19 pose a significant threat to the global healthcare system. These symptoms are yet to be synthesized and quantified via meta-analysis.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the prevalence of neurological and neuropsychiatric symptoms reported 12&#xa0;weeks (3&#xa0;months) or more after acute COVID-19 onset in adults.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">A systematic search of PubMed, EMBASE, Web of Science, Google Scholar and Scopus was conducted for studies published between January 1st, 2020 and August 1st, 2021. The systematic review was guided by Preferred Reporting Items for Systematic Review and Meta-Analyses.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Studies were included if the length of follow-up satisfied the National Institute for Healthcare Excellence (NICE) definition of post-COVID-19 syndrome (symptoms that develop or persist &#x2265;3&#xa0;months after the onset of COVID-19). Additional criteria included the reporting of neurological or neuropsychiatric symptoms in individuals with COVID-19.</AbstractText><AbstractText Label="DATA EXTRACTION AND SYNTHESIS" NlmCategory="METHODS">Two authors independently extracted data on patient characteristics, hospital and/or ICU admission, acute-phase COVID-19 symptoms, length of follow-up, and neurological and neuropsychiatric symptoms.</AbstractText><AbstractText Label="MAIN OUTCOME(S) AND MEASURE(S)" NlmCategory="METHODS">The primary outcome was the prevalence of neurological and neuropsychiatric symptoms reported &#x2265;3&#xa0;months post onset of COVID-19. We also compared post-COVID-19 syndrome in hospitalised vs. non-hospitalised patients, with vs. without ICU admission during the acute phase of infection, and with mid-term (3 to 6&#xa0;months) and long-term (&gt;6&#xa0;months) follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1458 articles, 19 studies, encompassing a total of 11,324 patients, were analysed. Overall prevalence for neurological post-COVID-19 symptoms were: fatigue (37%, 95% CI: 24%-50%), brain fog (32%, 9%-55%), memory issues (27%, 18%-36%), attention disorder (22%, 10%-34%), myalgia (18%, 4%-32%), anosmia (12%, 7%-17%), dysgeusia (11%, 4%-17%) and headache (10%, 1%-21%). Neuropsychiatric conditions included sleep disturbances (31%, 18%-43%), anxiety (23%, 13%-33%) and depression (12%, 7%-21%). Neuropsychiatric symptoms substantially increased in prevalence between mid- and long-term follow-up. Compared to non-hospitalised patients, patients hospitalised for acute COVID-19 had reduced frequency of anosmia, anxiety, depression, dysgeusia, fatigue, headache, myalgia, and sleep disturbance at three (or more) months post-infection. Conversely, hospital admission was associated with higher frequency of memory issues (OR: 1.9, 95% CI: 1.4-2.3). Cohorts with &gt;20% of patients admitted to the ICU during acute COVID-19 experienced higher prevalence of fatigue, anxiety, depression, and sleep disturbances than cohorts with &lt;20% of ICU admission.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Fatigue, cognitive dysfunction (brain fog, memory issues, attention disorder) and sleep disturbances appear to be key features of post-COVID-19 syndrome. Psychiatric manifestations (sleep disturbances, anxiety, and depression) are common and increase significantly in prevalence over time. Randomised controlled trials are necessary to develop intervention strategy to reduce disease burden.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Premraj</LastName><ForeName>Lavienraj</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Griffith University School of Medicine, Gold Coast, Australia; Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannapadi</LastName><ForeName>Nivedha V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Division of Neurosciences Critical Care, Department of Neurology, Neurosurgery, Anaesthesiology and Critical Care Medicine and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Griffith University School of Medicine, Gold Coast, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seal</LastName><ForeName>Stella M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>William H. Welch Medical Library, Johns Hopkins University School of Medicine, Baltimore, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battaglini</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy; Department of Medicine, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fanning</LastName><ForeName>Jonathon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia; Faculty of Medicine University of Queensland, Brisbane, QLD, Australia; St Andrew's War Memorial Hospital, UnitingCare, Spring Hill, QLD, Australia; Nuffield Department of Population Health, University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suen</LastName><ForeName>Jacky</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia; Faculty of Medicine University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robba</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy; Department of Surgical Science and Integrated Diagnostic, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia; Faculty of Medicine University of Queensland, Brisbane, QLD, Australia; St Andrew's War Memorial Hospital, UnitingCare, Spring Hill, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sung-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Neurosciences Critical Care, Department of Neurology, Neurosurgery, Anaesthesiology and Critical Care Medicine and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, United States of America. Electronic address: csungmi1@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL157610</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Neurol Sci</MedlineTA><NlmUniqueID>0375403</NlmUniqueID><ISSNLinking>0022-510X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurol Sci. 2022 May 15;436:120232. doi: 10.1016/j.jns.2022.120232</RefSource><PMID Version="1">35339066</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">ICU</Keyword><Keyword MajorTopicYN="Y">Long-COVID</Keyword><Keyword MajorTopicYN="Y">Long-Haulers</Keyword><Keyword MajorTopicYN="Y">Neuro-COVID-19</Keyword><Keyword MajorTopicYN="Y">PCNS</Keyword><Keyword MajorTopicYN="Y">Post-COVID-19 neurological syndrome</Keyword><Keyword MajorTopicYN="Y">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35121209</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pii">S0022-510X(22)00021-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw. Open. 2021;4(2):e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9(2):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26(7):1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K.K., Chaubey G., Chen J.Y., Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Phys. Cell Phys. 2020;319(2):C258&#x2013;c267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon L., McNamara C., Gaur P., et al. Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon? Stroke Vasc. Neurol. 2020;5(4):315&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7681795</ArticleId><ArticleId IdType="pubmed">33208493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawlani V., Scotton S., Nader K., et al. COVID-19-related intracranial imaging findings: a large single-centre experience. Clin. Radiol. 2021;76(2):108&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491990</ArticleId><ArticleId IdType="pubmed">33023738</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood&#x2013;brain barrier. Neurobiol. Dis. 2020;146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., Perl D.P., Nair G., et al. Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med. 2021;384(5):481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236&#xa0;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg. Health - Eur. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Soddu D., Balbo P.E., et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw. Open. 2021;4(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Inf. Secur. 2020;81(6):e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Group TWCftCS Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021;325(15):1525&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England) 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., et al. Cerebral micro-structural changes in COVID-19 patients &#x2013; an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.N., Hoang V.T., Lagier J.-C., Raoult D., Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin. Microbiol. Infect. 2021;27(6):931&#x2013;932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7784539</ArticleId><ArticleId IdType="pubmed">33418020</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G., Bertelloni D., Diolaiuti F., et al. Long-COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare. 2021;9(5):575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor R.R., Trivedi B., Patel N., et al. Post-COVID symptoms reported at asynchronous virtual review and stratified follow-up after COVID-19 pneumonia. Clin. Med. 2021;21(4):e384&#x2013;e391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8313189</ArticleId><ArticleId IdType="pubmed">34103378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugurlu B.N., Akdogan O., Yilmaz Y.A., et al. Quantitative evaluation and progress of olfactory dysfunction in COVID-19. Eur. Arch. Otorhinolaryngol. 2021;278(7):2363&#x2013;2369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7775637</ArticleId><ArticleId IdType="pubmed">33385250</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. SSRN Electron. J. 2021;38:7&#x2013;19. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte &#xc1;., Rivera-Izquierdo M., Guerrero-Fern&#xe1;ndez de Alba I., et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D., Ballouz T., Anagnostopoulos A., et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS One. 2021;16(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L., Ramezani M., Darazam I.A., et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J. Neuro-Oncol. 2021;27(1):154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 2021;426</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J., Ben&#xed;tez I.D., Carmona P., et al. Pulmonary function and radiologic features in survivors of critical COVID-19. Chest. 2021;160(1):187&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27(1):89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G., Shea B., O&#x2019;Connell J. Vol. 7. Ottawa Health Research Institute Web site; 2014. The Newcastle-Ottawa Scale (NOS) for Assessing The Quality of Nonrandomised Studies in Meta-analyses.</Citation></Reference><Reference><Citation>Modesti P.A., Reboldi G., Cappuccio F.P., et al. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One. 2016;11(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725677</ArticleId><ArticleId IdType="pubmed">26808317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidik K., Jonkman J.N. A comparison of heterogeneity variance estimators in combining results of studies. Stat. Med. 2007;26(9):1964&#x2013;1981.</Citation><ArticleIdList><ArticleId IdType="pubmed">16955539</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J., Ioannidis J.P.A., Borm G.F. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med. Res. Methodol. 2014;14(1):25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015721</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002;21(11):1539&#x2013;1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H., Strasser Z.H., Brat G.A., et al. Evolving phenotypes of non-hospitalized patients that indicate long covid. BMC Medicine. 2021;19:1&#x2013;10. 2021.2004.2025.21255923, 249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S., Najjar A., Chong D.J., et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J. Neuroinflammation. 2020;17(1):231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K., Zou J., Chang H.Y. RNA-GPS predicts SARS-CoV-2 RNA localization to host mitochondria and nucleolus. Cell Systems. 2020;11(1):102&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7305881</ArticleId><ArticleId IdType="pubmed">32673562</ArticleId></ArticleIdList></Reference><Reference><Citation>Generoso J.S., Barichello De Quevedo J.L., Cattani M., et al. Neurobiology of COVID-19: how can the virus affect the brain? Br. J. Psychiatr. 2021;43(6):650&#x2013;664. doi: 10.1590/1516-4446-2020-1488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-4446-2020-1488</ArticleId><ArticleId IdType="pmc">PMC8639021</ArticleId><ArticleId IdType="pubmed">33605367</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors. 2021;47(2):232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin C.M., Bjorvatn B., Chung F., et al. Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study. Sleep Med. 2021;87:38&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425785</ArticleId><ArticleId IdType="pubmed">34508986</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., et al. Persistent symptoms 3&#xa0;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020:00542&#x2013;02020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura S., Yoneoka D., Shi S., et al. An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency? Lancet Reg. Health - Western Pacific. 2020;1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453215</ArticleId><ArticleId IdType="pubmed">34173594</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorowitz R.D. ICU-acquired weakness: a rehabilitation perspective of diagnosis, treatment, and functional management. Chest. 2016;150(4):966&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pubmed">27312737</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen M.E., Christie J.D., Lanken P.N., et al. The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am. J. Respir. Crit. Care Med. 2012;185(12):1307&#x2013;1315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381234</ArticleId><ArticleId IdType="pubmed">22492988</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal G., Yadav S., Kumar R. Post-intensive care syndrome: an overview. J. Transl. Int. Med. 2017;5(2):90&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506407</ArticleId><ArticleId IdType="pubmed">28721340</ArticleId></ArticleIdList></Reference><Reference><Citation>Unoki T., Sakuramoto H., Uemura S., et al. Prevalence of and risk factors for post-intensive care syndrome: multicenter study of patients living at home after treatment in 12 Japanese intensive care units, SMAP-HoPe study. PLoS One. 2021;16(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158919</ArticleId><ArticleId IdType="pubmed">34043682</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni T.E., Medici V., Moretti M., et al. COVID-19-related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol. 2021;31(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412067</ArticleId><ArticleId IdType="pubmed">34145669</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon I.H., Normandin E., Bhattacharyya S., et al. Neuropathological features of Covid-19. N. Engl. J. Med. 2020;383(10):989&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Radnis C., Qiu S., Jhaveri M., Da Silva I., Szewka A., Koffman L. Radiographic and clinical neurologic manifestations of COVID-19 related hypoxemia. J. Neurol. Sci. 2020;418:117119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474836</ArticleId><ArticleId IdType="pubmed">32957036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowenstein C.J., Solomon S.D. Severe COVID-19 is a microvascular disease. Circulation. 2020;142(17):1609&#x2013;1611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7580651</ArticleId><ArticleId IdType="pubmed">32877231</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth S.F., Cho S.-M., Robba C., et al. Neurological manifestations of Coronavirus disease 2019: a comprehensive review and meta-analysis of the First 6 months of pandemic reporting. Front. Neurol. 2021;12:664599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8387564</ArticleId><ArticleId IdType="pubmed">34456840</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N., Di Napoli M., Biller J., et al. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21(9):44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>